Hemolytic anemia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
*Worldwide, the incidence of autoimmune hemolytic anemia is 0.8 per 100,000 persons.<ref name="pmid21747883">{{cite journal| author=Baek SW, Lee MW, Ryu HW, Lee KS, Song IC, Lee HJ et al.| title=Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases. | journal=Korean J Hematol | year= 2011 | volume= 46 | issue= 2 | pages= 111-7 | pmid=21747883 | doi=10.5045/kjh.2011.46.2.111 | pmc=3128891 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21747883 }} </ref> Some studies suggest that the incidence of autoimmune hemolytic anemia in adults in 1:100,000 persons.<ref name="pmid25705656">{{cite journal| author=Berentsen S, Sundic T| title=Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy. | journal=Biomed Res Int | year= 2015 | volume= 2015 | issue= | pages= 363278 | pmid=25705656 | doi=10.1155/2015/363278 | pmc=4326213 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25705656 }} </ref> The incidence of lower in children. | *Worldwide, the incidence of autoimmune hemolytic anemia is 0.8 per 100,000 persons.<ref name="pmid21747883">{{cite journal| author=Baek SW, Lee MW, Ryu HW, Lee KS, Song IC, Lee HJ et al.| title=Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases. | journal=Korean J Hematol | year= 2011 | volume= 46 | issue= 2 | pages= 111-7 | pmid=21747883 | doi=10.5045/kjh.2011.46.2.111 | pmc=3128891 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21747883 }} </ref> Some studies suggest that the incidence of [[autoimmune]] hemolytic anemia in adults in 1:100,000 persons.<ref name="pmid25705656">{{cite journal| author=Berentsen S, Sundic T| title=Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy. | journal=Biomed Res Int | year= 2015 | volume= 2015 | issue= | pages= 363278 | pmid=25705656 | doi=10.1155/2015/363278 | pmc=4326213 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25705656 }} </ref> The incidence of hemolytic anemia is lower in children. | ||
*Worldwide, the prevalence of autoimmune hemolytic anemia is 17 per 100,000 persons.<ref name="pmid21747883">{{cite journal| author=Baek SW, Lee MW, Ryu HW, Lee KS, Song IC, Lee HJ et al.| title=Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases. | journal=Korean J Hematol | year= 2011 | volume= 46 | issue= 2 | pages= 111-7 | pmid=21747883 | doi=10.5045/kjh.2011.46.2.111 | pmc=3128891 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21747883 }} </ref> | *Worldwide, the prevalence of autoimmune hemolytic anemia is 17 per 100,000 persons.<ref name="pmid21747883">{{cite journal| author=Baek SW, Lee MW, Ryu HW, Lee KS, Song IC, Lee HJ et al.| title=Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases. | journal=Korean J Hematol | year= 2011 | volume= 46 | issue= 2 | pages= 111-7 | pmid=21747883 | doi=10.5045/kjh.2011.46.2.111 | pmc=3128891 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21747883 }} </ref> | ||
*Worldwide, the incidence of drug-induced hemolytic anemia is 0.1 per 100,000 persons.<ref name="pmid26696800">{{cite journal| author=Packman CH| title=The Clinical Pictures of Autoimmune Hemolytic Anemia. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 317-24 | pmid=26696800 | doi=10.1159/000440656 | pmc=4678314 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696800 }} </ref> | *Worldwide, the incidence of drug-induced hemolytic anemia is 0.1 per 100,000 persons.<ref name="pmid26696800">{{cite journal| author=Packman CH| title=The Clinical Pictures of Autoimmune Hemolytic Anemia. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 317-24 | pmid=26696800 | doi=10.1159/000440656 | pmc=4678314 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696800 }} </ref> | ||
Latest revision as of 18:47, 30 October 2017
|
Hemolytic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemolytic anemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hemolytic anemia epidemiology and demographics |
|
Risk calculators and risk factors for Hemolytic anemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Shyam Patel [2]
Overview
In general, hemolytic anemia is a relatively rare condition. The incidence and prevalence are fairly low.
Epidemiology and Demographics
- Worldwide, the incidence of autoimmune hemolytic anemia is 0.8 per 100,000 persons.[1] Some studies suggest that the incidence of autoimmune hemolytic anemia in adults in 1:100,000 persons.[2] The incidence of hemolytic anemia is lower in children.
- Worldwide, the prevalence of autoimmune hemolytic anemia is 17 per 100,000 persons.[1]
- Worldwide, the incidence of drug-induced hemolytic anemia is 0.1 per 100,000 persons.[3]
Gender
- Hemolytic anemia affects men and women equally.
Race
- Hemolytic anemia affects all races equally.
Age
- Hemolytic anemia affects adults more commonly than children.[2]
References
- ↑ 1.0 1.1 Baek SW, Lee MW, Ryu HW, Lee KS, Song IC, Lee HJ; et al. (2011). "Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases". Korean J Hematol. 46 (2): 111–7. doi:10.5045/kjh.2011.46.2.111. PMC 3128891. PMID 21747883.
- ↑ 2.0 2.1 Berentsen S, Sundic T (2015). "Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy". Biomed Res Int. 2015: 363278. doi:10.1155/2015/363278. PMC 4326213. PMID 25705656.
- ↑ Packman CH (2015). "The Clinical Pictures of Autoimmune Hemolytic Anemia". Transfus Med Hemother. 42 (5): 317–24. doi:10.1159/000440656. PMC 4678314. PMID 26696800.